Historical return extremes for Novo Nordisk (NVO) from 1981 to 2026
What if you bought at the best or worst time? Max profit, max drawdown, and total return since IPO.
| Scenario | Return | Start date | Start price | End date | End price | $1,000 becomes |
|---|---|---|---|---|---|---|
| Max profitMore info about Max profit | +219,122% | $0.07 | $143.65 | $2,192,223.43 | ||
| Max drawdownMore info about Max drawdown | -75.43% | $143.65 | $35.29 | $245.67 | ||
| Return since IPOMore info about Return since IPO | +44,107% | $0.10 | $43.88 | $442,066.61 |
- Max profitMore info about Max profit+219,122%$2,192,223.43
- Max drawdownMore info about Max drawdown-75.43%$245.67
- Return since IPOMore info about Return since IPO+44,107%$442,066.61
Each row shows the start and end dates and prices for the scenario, the period return, and the resulting outcome for a $1,000 investment in Novo Nordisk (NVO). Max profit is the best buy-and-sell pair across the entire price history; max drawdown is the worst peak-to-trough decline; the last row tracks return from IPO to today. Prices are split- and dividend-adjusted closing prices — actual outcomes would differ due to fees, taxes, and slippage.
Frequently asked questions
Data & methodology
Novo Nordisk (NVO) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement